BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260224T150000
DTEND;TZID=Europe/Stockholm:20260224T160000
DTSTAMP:20260403T213128
CREATED:20260129T143238Z
LAST-MODIFIED:20260129T143240Z
UID:194019-1771945200-1771948800@www.scilifelab.se
SUMMARY:PULSE Challenge: Catalysis - A guiding principle for biochemistry and professional career development
DESCRIPTION:This seminar will describe Dr. Lorenz M. Mayr‘s experience in drug discovery from over 30 years in industry\, academia\, venture capital/financing and finally running Biotech startup companies. He is driven by his passion for science\, interdisciplinary research and impact for patients. The ultimate goal has always been to bring innovative\, impactful and affordable medicine to patients. He has had success by working in Germany\, US\, UK\, Sweden and Switzerland\, but also made a number of mistakes. Quote: I am happy to share my experience and to help new entrepreneurs to pursue a career in drug discovery\, at academia or industry\, but ideally with novel startup companies.  \n\n\n\nHost: Kristian SandbergModerator: Anna Ridderstad \n\n\n\nThe seminar series PULSE Challenge is connected to the MSCA co-funded* postdoctoral program SciLifeLab PULSE\, that will train 48 future leaders in life sciences. The program focuses on innovative\, fundamental and translational research carried out in supportive and diverse academic and industrial environments\, preparing postdocs with necessary skills for long-term career sustainability. Click HERE to find out more about SciLifeLab PULSE \n\n\n\n\n\n\n\nOn-line event via Zoom \n\n\n\nRegister Here\n\n\n\n\n\n\n\n\n\n\n\n\n\nPresenter: Dr. Lorenz M. Mayr  \n\n\n\nBiography:Lorenz is working as Managing Director at BioMedTech Consulting GmbH in Basel\, Switzerland. The company provides consulting service to BioPharma\, Biotechnology and MedTech companies and academic institutions. He is also working as Chief Executive Officer (CEO) and Chairman of the Board (President) of PHiNE Bio AG\, a new Biotech startup company in Basel\, Switzerland which is operating since 08/2025 in stealth mode and financed by private investors. \n\n\n\nLorenz has long-lasting experience in Pharma/Biotech investments and company creation from his work at Syncona Ltd (London\, UK)\, Hevolution Foundation (Boston\, MA) and EIT-Health Gold Track (Boston\, MA; Munich\, Germany). Lorenz is a highly respected biopharmaceutical executive with extensive experience over the last 30 years in drug discovery\, technology and innovation\, business growth and financing strategy. \n\n\n\nHe has previously worked as a Chairman\, Non-Executive Director\, Chief Executive Officer\, Chief Technology Officer\, and Entrepreneur-in-Residence in the Biotech\, Medtech\, Pharma and Venture Capital industry across Europe and the US. \n\n\n\nHe has received first class degrees in biochemistry\, biophysics\, molecular & cell biology at the University of Tubingen (Germany)\, University of Bayreuth (Germany) and the University of Colorado at Boulder (U.S.A.) and a number of fellowships & awards for his studies in Germany and the United States. \n\n\n\nLorenz currently serves on the Board of Directors at Fundamental Pharma (Heidelberg\, Germany)\, InCephalo (Basel\, Switzerland) and PHiNE Bio AG (Basel\, Switzerland)\, and serves on the Scientific Advisory Board of Fraunhofer IGB (Stuttgart\, Germany)\, Fraunhofer IZI (Leipzig\, Germany)\, SaxoCell (Leipzig)\, The Francis Crick Institute (London\, UK)\, Science4Life (Stockholm\, Sweden) SensibleBio (Oxford\, UK)\, Hemotune (Zurich\, Switzerland)\, Huidagene (Shanghai\, China)\, AstraGenomics (Shanghai\, China)\, TQ Therapeutics (Munich\, Germany)\, GeneFab (San Francisco\, CA) and NanoVation (Vancouver\, Canada)\, and works as Senior Healthcare Advisor to EQT Investments (Stockholm/Sweden).
URL:https://www.scilifelab.se/event/pulse-challenge-catalysis-a-guiding-principle-for-biochemistry-and-professional-career-development/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2025/02/Bild1-e1770905208628.png
END:VEVENT
END:VCALENDAR